Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Plus Therapeutics (PSTV) Interest Coverage Ratio (2016 - 2025)

Plus Therapeutics has reported Interest Coverage Ratio over the past 15 years, most recently at 6.45 for Q1 2025.

  • Quarterly Interest Coverage Ratio rose 93.35% to 6.45 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was 27.92 through Dec 2025, up 66.0% year-over-year, with the annual reading at 27.92 for FY2025, 66.0% up from the prior year.
  • Interest Coverage Ratio was 6.45 for Q1 2025 at Plus Therapeutics, up from 68.42 in the prior quarter.
  • Over five years, Interest Coverage Ratio peaked at 6.45 in Q1 2025 and troughed at 136.93 in Q2 2024.
  • The 5-year median for Interest Coverage Ratio is 31.48 (2022), against an average of 43.03.
  • Year-over-year, Interest Coverage Ratio tumbled 929.24% in 2024 and then skyrocketed 93.35% in 2025.
  • A 5-year view of Interest Coverage Ratio shows it stood at 15.08 in 2021, then tumbled by 232.84% to 50.2 in 2022, then decreased by 23.96% to 62.23 in 2023, then fell by 9.96% to 68.42 in 2024, then soared by 90.57% to 6.45 in 2025.
  • Per Business Quant, the three most recent readings for PSTV's Interest Coverage Ratio are 6.45 (Q1 2025), 68.42 (Q4 2024), and 62.28 (Q3 2024).